The International Rare Diseases Research Consortium hopes to develop 200 new drugs for rare diseases by 2020, and it seems as if things are better than on track.
Pharmacy Best Practices
Some of the most amazing things are happening in the delivery of medical care these days. Surgical techniques, new devices, drugs, and diagnostics can treat and cure many medical conditions.
Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.
Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications
A new study sheds light on PDMPs and their effectiveness in tackling the opioid crisis and includes one disturbing finding you won’t believe.
The new Bipartisan Budget Act of 2018, to be in effect on January 2019, institutes new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.
How skipping industry acronyms and jargon and using simple terminology will eliminate confusion and misinterpretation.
A Surescripts survey reveals the need for more interoperable access to patient data in three major areas.
An ONC report finds that more patients are engaged with their health records. Here’s why.
The goal is to help ensure that prescription drug marketing information for consumers and healthcare providers is truthful and balanced. Here’s what the agency plans to research.